title: Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit.
abstract: It is uncertain what should be done with insulin dose if starting exenatide. In the ABCD nationwide exenatide audit, many patients with type 2 diabetes had worsened glycaemia when insulin was stopped. If starting exenatide, insulin should not be stopped but weaned off only if there is significant glycaemic response.
authors.affiliation: City Hospital, Birmingham, United Kingdom. Electronic address: kythong@gmail.com.
authors.forename: K Y
authors.initials: KY
authors.lastname: Thong
authors.affiliation: City Hospital, Birmingham, United Kingdom.
authors.forename: B
authors.initials: B
authors.lastname: Jose
authors.affiliation: City Hospital, Birmingham, United Kingdom.
authors.forename: A D
authors.initials: AD
authors.lastname: Blann
authors.affiliation: City Hospital, Birmingham, United Kingdom.
authors.forename: M L
authors.initials: ML
authors.lastname: Cull
authors.affiliation: City Hospital, Birmingham, United Kingdom.
authors.forename: A P
authors.initials: AP
authors.lastname: Mills
authors.affiliation: Hull Royal Infirmary, Hull, United Kingdom.
authors.forename: T
authors.initials: T
authors.lastname: Sathyapalan
authors.affiliation: Hull Royal Infirmary, Hull, United Kingdom.
authors.forename: C
authors.initials: C
authors.lastname: Walton
authors.affiliation: City Hospital, Birmingham, United Kingdom.
authors.forename: R E J
authors.initials: REJ
authors.lastname: Ryder
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D000077270:Exenatide; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000627:therapeutic use*; D012189:Retrospective Studies; D006113:United Kingdom; D014688:Venoms / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010455:Peptides; D014688:Venoms; D000077270:Exenatide